CBS 2019
CBSMD教育中心
English

动脉粥样硬化性心血管疾病预防

科研文章

荐读文献

Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000: Results From the CAC Consortium Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality Myocardial bridging of the left anterior descending coronary artery is associated with reduced myocardial perfusion reserve: a 13N-ammonia PET study Clinical Risk Factors and Atherosclerotic Plaque Extent to Define Risk for Major Events in Patients Without Obstructive Coronary Artery Disease: The Long-Term Coronary Computed Tomography Angiography CONFIRM Registry Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When
|<<... 6 7 8 9 10 11 12 ...>>|

Guideline2018 Sep 25;138(13):e415-e418.

JOURNAL：Circulation. Article Link

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Al-Khatib SM, Stevenson WG, Ackerman MJ et al. Keywords: AHA Scientific Statements; CT imaging; ECG; MR imaging; acute coronary syndrome; ambulatory ECG monitoring; antiarrhythmic drug therapy; arrhythmogenic cardiomyopathy; athletes; cardiac electrophysiology; cardiac resynchronization therapy; cardiomyopathy; catheter ablation; congenital heart disease; echocardiography; electrophysiological testing; genetic arrhythmias; guidelines; heart failure; imaging; implantable and external cardioverter devices; implantable cardioverter-defibrillator; medication-induced arrhythmias; myocardial infarction; premature ventricular beats; resuscitation; sarcoidosis; specific pathology (eg, congenital heart disease, myocarditis, renal failure); stable coronary artery disease; sudden cardiac arrest; sudden cardiac death; torsades de pointes; ventricular fibrillation; ventricular tachycardia

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top